Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

The role of dynamic, contrast-enhanced MRI in differentiating lung tumor subtypes.

Pauls S, Breining T, Muche R, Schmidt SA, Wunderlich A, Krüger S, Brambs HJ, Feuerlein S.

Clin Imaging. 2011 Jul-Aug;35(4):259-65. doi: 10.1016/j.clinimag.2010.07.002.

PMID:
21724117
2.

Evaluation of lung tumor perfusion by dynamic contrast-enhanced MRI.

Pauls S, Mottaghy FM, Schmidt SA, Krüger S, Möller P, Brambs HJ, Wunderlich A.

Magn Reson Imaging. 2008 Dec;26(10):1334-41. doi: 10.1016/j.mri.2008.04.005. Epub 2008 Jun 5.

PMID:
18538522
3.

Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn's disease.

Giusti S, Faggioni L, Neri E, Fruzzetti E, Nardini L, Marchi S, Bartolozzi C.

Abdom Imaging. 2010 Dec;35(6):646-53. doi: 10.1007/s00261-010-9624-6.

PMID:
20509025
4.

Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.

Huang W, Hu J, Yang DW, Fan XT, Jin Y, Hou YY, Wang JP, Yuan YF, Tan YS, Zhu XZ, Bai CX, Wu Y, Zhu HG, Lu SH.

Am J Respir Crit Care Med. 2012 Dec 1;186(11):1160-7. doi: 10.1164/rccm.201203-0534OC. Epub 2012 Oct 4.

PMID:
23043084
5.

Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.

Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RA, Brenton JD, Lomas DJ, Sala E.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):766-73. doi: 10.1016/j.ijrobp.2008.08.023. Epub 2008 Nov 18.

PMID:
19019563
6.

Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S.

AJNR Am J Neuroradiol. 2009 Feb;30(2):367-72. doi: 10.3174/ajnr.A1362. Epub 2008 Nov 20.

7.

Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis.

Schaefer JF, Schneider V, Vollmar J, Wehrmann M, Aebert H, Friedel G, Vonthein R, Schick F, Claussen CD.

Lung Cancer. 2006 Jul;53(1):39-49. Epub 2006 May 11.

PMID:
16690161
8.

MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA.

Crisci R, Di Cesare E, Lupattelli L, Coloni GF.

Eur J Cardiothorac Surg. 1997 Feb;11(2):214-7.

PMID:
9080145
9.
10.

Magnetic resonance imaging in peripheral lung adenocarcinoma: correlation with histopathologic features.

Tanaka R, Horikoshi H, Nakazato Y, Seki E, Minato K, Iijima M, Kojima M, Goya T.

J Thorac Imaging. 2009 Feb;24(1):4-9. doi: 10.1097/RTI.0b013e31818703b7.

PMID:
19242296
11.

Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient.

Nakayama J, Miyasaka K, Omatsu T, Onodera Y, Terae S, Matsuno Y, Cho Y, Hida Y, Kaga K, Shirato H.

J Comput Assist Tomogr. 2010 Jan;34(1):1-8. doi: 10.1097/RCT.0b013e3181a9cc07.

PMID:
20118713
12.

Dynamic MR imaging: value of differentiating subtypes of peripheral small adenocarcinoma of the lung.

Ohno Y, Hatabu H, Takenaka D, Uematsu H, Ohbayashi C, Higashino T, Nogami M, Yoshimura M, Fujii M, Sugimura K.

Eur J Radiol. 2004 Nov;52(2):144-50.

PMID:
15489071
13.

Diffusion-weighted magnetic resonance imaging in differentiating the invasiveness of small lung adenocarcinoma.

Tanaka R, Horikoshi H, Yoshida T, Nakazato Y, Seki E, Goya T.

Acta Radiol. 2011 Sep 1;52(7):750-5. doi: 10.1258/ar.2011.110108. Epub 2011 May 12.

PMID:
21565888
14.

[Clinical studies for usefulness of Gd-DTPA enhanced MRI in lung cancer].

Kusumoto M.

Nihon Igaku Hoshasen Gakkai Zasshi. 1992 Mar 25;52(3):358-71. Japanese.

PMID:
1315952
15.

[Transbronchial biopsy of the lung in the diagnosis of peripheral cancer and diffuse-disseminated processes].

Lebedev VA, Blinchevskiĭ ID.

Sov Med. 1990;(9):107-11. Russian. No abstract available.

PMID:
2176348
16.

Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.

Inan N, Arslan A, Akansel G, Anik Y, Balci NC, Demirci A.

Eur J Radiol. 2008 Jan;65(1):154-62. Epub 2007 Apr 26.

PMID:
17466481
17.

Prognostic value of dynamic MR imaging for non-small-cell lung cancer patients after chemoradiotherapy.

Ohno Y, Nogami M, Higashino T, Takenaka D, Matsumoto S, Hatabu H, Sugimura K.

J Magn Reson Imaging. 2005 Jun;21(6):775-83.

PMID:
15906341
18.

Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer.

Picardo AL, Torres AJ, Maestro M, Ortega D, Garcia-Asenjo JA, Mugüerza JM, Hernando F, Diez M, Balibrea JL.

Cancer. 1994 May 1;73(9):2305-11.

19.

Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category.

Edwards SL, Roberts C, McKean ME, Cockburn JS, Jeffrey RR, Kerr KM.

J Clin Pathol. 2000 Jul;53(7):537-40.

20.

[Lung cancer at a university hospital: epidemiological and histological characteristics of a recent and a historical series].

Santos-Martínez MJ, Curull V, Blanco ML, Macià F, Mojal S, Vila J, Broquetas JM.

Arch Bronconeumol. 2005 Jun;41(6):307-12. Review. Spanish.

Supplemental Content

Support Center